Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Waterloo

$25,000.00

Multiple Diseases Discrimination through Blood Biomarkers Analysise

EF 2012-13

Résumé
Most people do not undergo regular screening for various diseases because traditional screening methods including biopsy, cytopathology, and MRI are generally inconvenient, expensive, and time-consuming. According to a special report by the Canadian Cancer Society, fewer Canadians would die from cancer if cancer screening in Canada was enhanced and expanded. That is why the development of accurate blood tests for multiple diseases discrimination is important. Such blood tests become a convenient way to undergo testing without waiting for months for traditional screening methods. With the advancement in microarray technology, it is now possible to collect massive amounts of blood RNA expression profiling data, which contains biomarkers for discriminating multiple diseases including colorectal cancer and prostate cancer. The availability of a rich dataset allows early testing that can reduce the disease occurrence rate and detecting diseases early before signs or symptoms of diseases appear, improving the likelihood of successful treatment through a simple blood test procedure. The challenge is accurately and efficiently detecting multiple diseases from a blood sample. If this challenge can be overcome, quicker identification will reduce suffering, morbidity and health care costs. The objective of this project is to develop a predictive method that will quickly and accurately detect multiple diseases through a large set of blood sample data for the industrial partner, GeneNews Limited. While GeneNews has massive amounts of blood RNA expression profiling data, their current prediction method has relatively low accuracy and takes weeks to discriminate diseases from the data. Therefore, a prediction technology that can more accurately and quickly detect diseases is required.
Programme
Engage Grants Program
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
435465-2012
Name nom
Wong, Andrew
Department département
Systems Design Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
2800
Research subject group en
Artificial intelligence
Research subject group fr
Intelligence artificielle
Research subject en
Artificial intelligence (computer vision, use2603)
Research subject fr
Intelligence artificielle (vision artificielle, utiliser 2603)
Partie
1
Nb partie
1
Application title
Multiple Diseases Discrimination through Blood Biomarkers Analysise
Keyword
NSERC
Application summary
Most people do not undergo regular screening for various diseases because traditional screening methods including biopsy, cytopathology, and MRI are generally inconvenient, expensive, and time-consuming. According to a special report by the Canadian Cancer Society, fewer Canadians would die from cancer if cancer screening in Canada was enhanced and expanded. That is why the development of accurate blood tests for multiple diseases discrimination is important. Such blood tests become a convenient way to undergo testing without waiting for months for traditional screening methods. With the advancement in microarray technology, it is now possible to collect massive amounts of blood RNA expression profiling data, which contains biomarkers for discriminating multiple diseases including colorectal cancer and prostate cancer. The availability of a rich dataset allows early testing that can reduce the disease occurrence rate and detecting diseases early before signs or symptoms of diseases appear, improving the likelihood of successful treatment through a simple blood test procedure. The challenge is accurately and efficiently detecting multiple diseases from a blood sample. If this challenge can be overcome, quicker identification will reduce suffering, morbidity and health care costs. The objective of this project is to develop a predictive method that will quickly and accurately detect multiple diseases through a large set of blood sample data for the industrial partner, GeneNews Limited. While GeneNews has massive amounts of blood RNA expression profiling data, their current prediction method has relatively low accuracy and takes weeks to discriminate diseases from the data. Therefore, a prediction technology that can more accurately and quickly detect diseases is required.